UroGen Pharma Announces Date for ENVISION Data, New Long-Ter

UroGen Pharma Announces Date for ENVISION Data, New Long-Term Jelmyto Durability Data, and Reports 2024 First Quarter Financial Results and Business Highlights

UroGen Pharma Announces Date for ENVISION Data, New Long-Term Jelmyto Durability Data, and Reports 2024 First Quarter Financial Results and Business Highlights

marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Israel , San Antonio , Texas , United States , American , Urogen Pharma , Liz Barrett , Urogen Rtgel , Drug Administration , American Urological Association , Nasdaq , Urogen Pharma Ltd , Company Investigational New Drug , Chief Executive Officer , Recent Business Highlights , New Drug Application , Investigational New Drug , Prepaid Forward Obligation , Long Term Debt , Pharmakon Advisors , Cash Equivalents , Operating Expense , Webcast Information , Upper Tract Urothelial Cancer , Prescribing Information , Patient Information , Utilizing Urogen , Private Securities Litigation Reform Act , Risk Factors , Annual Report , Quarterly Report ,